Envista Holdings' Short Interest Falls 14.52%, Down 6.89% of Float

Envista Holdings' short interest has fallen 14.52% since its last report, with 9.40 million shares sold short, which is 6.89% of all regular shares available for trading. This decline in short interest may signal that investors have become more bullish on the company. Compared to its peers, Envista Holdings has less short interest, which could be a positive indicator for the stock.

Title: Envista Holdings' Short Interest Declines, Signaling Potential Bullish Sentiment

Envista Holdings' (NVST) short interest has fallen significantly, indicating a potential shift in investor sentiment. As of July 2, 2025, the company's short interest has decreased by 14.52%, with 9.40 million shares sold short, representing 6.89% of all regular shares available for trading [1]. This decline in short interest suggests that investors may be becoming more bullish on the company.

The short interest ratio, also known as the "days to cover ratio," for NVST has improved to 5.0, indicating a reduction in pessimism among investors [1]. This ratio is calculated by dividing the number of shares sold short by the average trading volume, with a ratio between 1 and 4 generally indicating positive sentiment. A ratio of 10 or greater suggests strong pessimism.

Institutional investors, such as Walleye Trading LLC, Simplex Trading LLC, and Polar Asset Management Partners Inc., have reported short positions in Envista, but the overall short interest has been decreasing [1]. This decrease may be a positive sign, as it suggests fewer investors are betting against the stock.

Comparatively, Envista Holdings has less short interest than its peers. For instance, BellRing Brands Inc. has a short interest of 3.61%, while Soleno Therapeutics, Inc. has a short interest of 13.40% [1]. This lower short interest relative to competitors could be a positive indicator for the stock.

The decline in short interest coincides with positive industry trends and the company's strong performance. According to Zacks Equity Research, the medical products industry is facing challenges, but companies like Envista Holdings are adapting and witnessing a rise in their share price [2]. The company has reported diversified growth across equipment, consumables, and specialty products, and has shown operational improvements, including a 15% G&A reduction and manufacturing expansion in Suzhou, China.

In conclusion, the decline in Envista Holdings' short interest may signal that investors are becoming more optimistic about the company's prospects. This trend, combined with the company's strong performance and industry outlook, could be a positive indicator for the stock.

References:
[1] https://www.marketbeat.com/stocks/NYSE/NVST/short-interest/
[2] https://www.nasdaq.com/articles/zacks-industry-outlook-highlights-envista-biolife-solutions-infusystems-and-marimed